These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11851755)

  • 1. Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders.
    Messick K; Sanders JC; Goedert JJ; Eyster ME
    Haemophilia; 2001 Nov; 7(6):568-74. PubMed ID: 11851755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.
    Cribier B; Rey D; Schmitt C; Lang JM; Kirn A; Stoll-Keller F
    AIDS; 1995 Oct; 9(10):1131-6. PubMed ID: 8519448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia.
    Eyster ME; Sanders J; Goedert JJ
    Haemophilia; 2004 Jan; 10(1):75-80. PubMed ID: 14962224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
    Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
    J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C at the israeli national hemophilia center.
    Maor Y; Bashari D; Kenet G; Lalezari S; Lubetsky A; Luboshitz J; Schapiro JM; Avidan B; Bar-Meir S; Martinowitz U
    Haemophilia; 2006 Jan; 12(1):68-74. PubMed ID: 16409178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.
    Ghany MG; Leissinger C; Lagier R; Sanchez-Pescador R; Lok AS
    Dig Dis Sci; 1996 Jun; 41(6):1265-72. PubMed ID: 8654162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections.
    Tuveri R; Rothschild C; Pol S; Reijasse D; Persico T; Gazengel C; Bréchot C; Thiers V
    J Med Virol; 1997 Jan; 51(1):36-41. PubMed ID: 8986947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hepatitis C virus RNA replication in haemophiliacs: role of co-infection with human immunodeficiency virus.
    Chambost H; Gerolami V; Halfon P; Thuret I; Michel G; Sicardi F; Rousseau S; Perrimond H; Cartouzou G
    Br J Haematol; 1995 Nov; 91(3):703-7. PubMed ID: 8555079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
    Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV].
    Fedorchenko SV; Martynovich TL; Liashok OV; Kariuk ZhA; Ianchenko VI
    Ter Arkh; 2010; 82(3):52-6. PubMed ID: 20564924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.
    Beld M; Penning M; van Putten M; van den Hoek A; Lukashov V; McMorrow M; Goudsmit J
    J Clin Microbiol; 1998 Oct; 36(10):3002-6. PubMed ID: 9738057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV.
    Yoon SK; Park YM; Byun BH; Bae SH; Yang JM; Ahn BM; Lee YS; Lee CD; Sun HS; Kim BS
    Korean J Intern Med; 2000 Jul; 15(2):109-16. PubMed ID: 10992722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
    Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
    Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease.
    Ichimura H; Tamura I; Kurimura O; Koda T; Mizui M; Tsuchie H; Kurimura T
    J Med Virol; 1994 Jul; 43(3):212-5. PubMed ID: 7523579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus-infected, HCV-RNA-negative patients with bleeding disorders--relationship to age, HIV and treatment.
    Schulman S; Von Sydow M; Petrini P; Fahlstadius P
    Scand J Infect Dis; 1998; 30(5):455-8. PubMed ID: 10066043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
    Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
    J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
    Cavazza S; Lagging M
    Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.